Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Carcinoma, Non-Small-Cell Lung 10Lung Neoplasms 5Prostatic Neoplasms 4Breast Neoplasms 4Oropharyngeal Neoplasms 3Neoplasms 3Endometrial Neoplasms 3Stomach Neoplasms 2Rectal Neoplasms 2Pancreatic Neoplasms 2Urinary Bladder Neoplasms 1Ureteral Neoplasms 1Triple Negative Breast Neoplasms 1Thyroid Neoplasms 1Thyroid Diseases 1Stage I Mixed Cell Type Kidney Wilms Tumor 1Squamous Cell Carcinoma of Head and Neck 1Smoldering Multiple Myeloma 1Small Cell Lung Carcinoma 1Salivary Gland Neoplasms 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Pneumonia 1Pleuropulmonary blastoma 1Pathologic Complete Response 1Paranasal Sinus Neoplasms 1Pancreatitis, Chronic 1Obesity 1Neurocognitive Disorders 1Neuroblastoma 1Neoplasm Metastasis 1

Interventions

pembrolizumab 66Cisplatin 40Carboplatin 25Cetuximab 23Magnetic Resonance Spectroscopy 19Paclitaxel 18Nivolumab 17Specimen Handling 16Radiotherapy, Intensity-Modulated 16Radiotherapy 14Docetaxel 13Platinum 121,2-diaminocyclohexaneplatinum II citrate 11Fluorouracil 9Taxes 8Biopsy 8atezolizumab 6cemiplimab 5Surgical Procedures, Operative 5Radiation 5Ipilimumab 5(225)Ac-DOTA-c(RGDyK) 5dostarlimab 4Standard of Care 4Immunoglobulin G 4Immune Checkpoint Inhibitors 4Cyclophosphamide 4Bevacizumab 4Albumin-Bound Paclitaxel 4toripalimab 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Squamous Cell Carcinoma of Head and Neck × Observation × 90 days × Clear all
NCT07513324 2026-04-07

Risk-adapted Therapy in HPV-positive Oropharyngeal Cancer Using Circulating Tumor (ct) HPV DNA Profiling (ReACT 2.0)

Dana-Farber Cancer Institute

Phase 2 Not yet recruiting
116 enrolled
Head & Neck

Squamous Cell Carcinoma of Head and Neck

Data powered by HemOnc (CC BY 4.0) Colophon âš¡